title: Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial.
abstract: BACKGROUND
  Binge-eating disorder (BED) is defined by recurrent binge eating (eating unusually large quantities of food during which a subjective loss of control is experienced), marked distress about the binge eating, and the absence of inappropriate weight compensatory behaviors. BED is strongly associated with excess weight, and many available psychological and pharmacologic approaches fail to produce much weight loss. The objective of this study was to perform a randomized placebo-controlled trial to evaluate the short-term efficacy of bupropion for the treatment of BED in overweight and obese women.
  
  
  METHODS
  Sixty-one overweight and obese (mean body mass index [BMI] = 35.8) women who met DSM-IV-TR research criteria for BED were randomly assigned to receive bupropion (300 mg/d) or placebo for 8 weeks. Participants were enrolled from November 2006 to December 2010. No dietary or lifestyle intervention was given. Primary outcome measures were binge-eating frequency and percent BMI loss. Secondary outcome measures were dimensional measures of eating disorder psychopathology, food craving, and depression levels.
  
  
  RESULTS
  Eighty-nine percent (n = 54) of randomized participants completed the trial, without differential dropout between the bupropion and placebo groups. Mixed-effects analyses revealed significant time effects for all outcomes but no significant differences between bupropion and placebo on any outcome measure except for weight loss. Participants taking bupropion lost significantly more weight (1.8% vs 0.6% BMI loss; F = 10.57, P = .002).
  
  
  CONCLUSIONS
  Bupropion was well tolerated and produced significantly greater-albeit quite modest-short-term weight loss in overweight and obese women with BED. Bupropion did not improve binge eating, food craving, or associated eating disorder features or depression relative to placebo. Our findings do not support bupropion as a stand-alone treatment for BED. The preliminary findings regarding short-term weight losses suggest the need for larger and longer-term trials to evaluate the potential utility of bupropion for enhancing outcomes of psychological interventions that have demonstrated effectiveness for BED but fail to produce weight loss.
  
  
  BACKGROUND
  ClinicalTrials.gov identifier: NCT00414167
authors: Department of Psychiatry, Yale University School of Medicine, 301 Cedar St, PO Box 208098, New Haven, CT 06520, USA. marney.white@yale.edu
authors: Marney A
authors: MA
authors: White
authors: Carlos M
authors: CM
authors: Grilo
mesh_terms: D000328:Adult; D015992:Body Mass Index; D002032:Bulimia / Q000188:drug therapy*; D016642:Bupropion / Q000008:administration & dosage* / Q000009:adverse effects; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy; D050177:Overweight / Q000188:drug therapy*; D016896:Treatment Outcome; D015431:Weight Loss / Q000187:drug effects
chemical_list: D018765:Dopamine Uptake Inhibitors; D016642:Bupropion
references: Biol Psychiatry. 2005 Feb 1;57(3):301-9
references: 15691532
references: Eat Behav. 2005 Jun;6(3):239-45
references: 15854870
references: Nicotine Tob Res. 2004 Feb;6(1):27-37
references: 14982685
references: Obes Res. 2005 Oct;13(10):1701-8
references: 16286517
references: J Clin Psychiatry. 2007 Sep;68(9):1324-32
references: 17915969
references: Psychol Methods. 2002 Mar;7(1):41-63
references: 11928890
references: J Consult Clin Psychol. 1996 Feb;64(1):109-20
references: 8907090
references: Psychol Bull. 1991 Jul;110(1):86-108
references: 1891520
references: Psychiatry Res. 2004 Apr 30;130(3):269-81
references: 15135160
references: Am J Psychiatry. 2008 Jan;165(1):51-8
references: 18056225
references: Int J Eat Disord. 2004 Dec;36(4):434-44
references: 15558644
references: Biol Psychiatry. 2010 Apr 15;67(8):793-5
references: 20060105
references: Arch Gen Psychiatry. 2004 Mar;61(3):310-7
references: 14993119
references: Int J Eat Disord. 2009 Dec;42(8):687-705
references: 19621466
references: J Clin Psychiatry. 2002 Nov;63(11):1028-33
references: 12444817
references: Obes Res. 2002 Oct;10(10):1049-56
references: 12376586
references: N Engl J Med. 1999 Mar 4;340(9):685-91
references: 10053177
references: Am Psychol. 2007 Apr;62(3):199-216
references: 17469898
references: Obes Res. 2002 Jul;10(7):633-41
references: 12105285
references: J Clin Psychiatry. 2006 Dec;67(12):1897-906
references: 17194267
references: Arch Intern Med. 2007 Sep 10;167(16):1791-7
references: 17846399
references: J Psychopharmacol. 2011 Oct;25(10):1269-76
references: 21169392
references: J Consult Clin Psychol. 2001 Dec;69(6):1066-72
references: 11777111
references: N Engl J Med. 1997 Oct 23;337(17):1195-202
references: 9337378
references: Obes Res. 2001 Jul;9(7):418-22
references: 11445665
references: J Consult Clin Psychol. 2012 Dec;80(6):1108-13
references: 22985205
references: Biol Psychiatry. 2005 May 15;57(10):1193-201
references: 15866560
references: Am J Psychiatry. 2000 Jun;157(6):1004-6
references: 10831483
references: Int J Eat Disord. 2011 Jan;44(1):81-90
references: 21080416
references: Obesity (Silver Spring). 2008 Sep;16(9):2024-38
references: 19186327
references: Curr Drug Targets. 2005 Mar;6(2):191-9
references: 15777189
references: J Consult Clin Psychol. 2001 Apr;69(2):317-22
references: 11393608
references: J Consult Clin Psychol. 2011 Oct;79(5):675-85
references: 21859185
references: Neuropharmacology. 2002 Feb;42(2):181-90
references: 11804614
references: J Clin Psychiatry. 1988 Jul;49(7):262-6
references: 3134343
references: Psychother Psychosom. 2001 Nov-Dec;70(6):298-306
references: 11598429
references: J Abnorm Psychol. 2008 May;117(2):414-9
references: 18489217
references: Am J Clin Nutr. 2010 Jun;91(6):1568-73
references: 20427731
references: Am J Psychiatry. 2003 Feb;160(2):255-61
references: 12562571
references: Behav Res Ther. 2009 Aug;47(8):692-6
references: 19552897
references: J Psychiatry Neurosci. 2004 Mar;29(2):134-7
references: 15069467
references: J Consult Clin Psychol. 2006 Jun;74(3):602-13
references: 16822116
references: Int J Eat Disord. 2004 Jan;35(1):80-5
references: 14705160
references: Biol Psychiatry. 2007 Feb 1;61(3):348-58
references: 16815322
references: Obes Res. 2002 Feb;10(2):107-14
references: 11836456